CN-764

N/A

Report date: 2024/01/25 09:18:04

Base Information

Drug NameCN-764

Drug Alias NameN/A

ClassificationBiologics > Oncolytic virus

Mechanisms of ActionCyclooxygenases inhibitors

TargetsCyclooxygenases

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCalydon Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCalydon Inc

Active IndicationsN/A

Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A

Related LinksN/A